✦ LIBER ✦

Phase II study of single-agent etoposide in patients with metastatic squamous-cell carcinoma of the esophagus

✍ Scribed by Andreas Harstrick; Carsten Bokemeyer; Peter Preusser; Claus Henning Köhne-Wömpner; Hans-Joachim Meyer; Michael Stahl; Heike Knipp; Hans-Joachim Schmoll; Hansjochen Wilke

Publisher: Springer
Year: 1992
Tongue: English
Weight: 215 KB
Volume: 29
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685952

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of lenalidomide in patien

Phase II study of lenalidomide in patients with metastatic renal cell carcinoma

✍ Toni K. Choueiri; Robert Dreicer; Brian I. Rini; Paul Elson; Jorge A. Garcia; Sn 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 438 KB 👁 1 views

Phase II study of the antiangiogenesis a

Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck

✍ Jennifer E. Tseng; Bonnie S. Glisson; Fadlo R. Khuri; Dong M. Shin; Jeffrey N. M 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB 👁 3 views

Squamous cell carcinoma of the esophagus

Squamous cell carcinoma of the esophagus in patients with Acquired Immunodeficiency Syndrome

✍ Frager, David H. ;Wolf, Ellen L. ;Competiello, Louis S. ;Frager, Joseph D. ;Klei 📂 Article 📅 1988 🏛 Springer-Verlag 🌐 English ⚖ 764 KB

Phase II trial of tamoxifen, etoposide,

Phase II trial of tamoxifen, etoposide, mitoxantrone, and cisplatin in patients with metastatic breast carcinoma

✍ Suzanne D. Conzen; Peter A. Kaufman; Christine Arvizu; Paul LeMarbre; L. Herbert 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 554 KB

## BACKGROUND. Based on previous data demonstrating a potentially synergistic interaction between tamoxifen and cisplatin in metastatic melanoma therapy, a Phase I1 study was performed to assess the activity of tamoxifen, etoposide, mitoxantrone, and cisplatin (TEMP) in patients with metastatic br

Phase II study of paclitaxel, ifosfamide

Phase II study of paclitaxel, ifosfamide, and carboplatin in patients with recurrent or metastatic head and neck squamous cell carcinoma

✍ Dong M. Shin; Fadlo R. Khuri; Bonnie S. Glisson; Lawrence Ginsberg; Vali M. Papa 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB 👁 2 views

Phase II trial of piroxantrone in patien

Phase II trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck

✍ Sarah A. Taylor; Jacqueline Benedetti; David Schuller; Stephen P. Richman; Goron 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 161 KB